BHSRX | THISX | BHSRX / THISX | |
Total Expense Ratio | 1.46 | 0.67 | 218% |
Annual Report Gross Expense Ratio | 1.46 | 0.67 | 218% |
Fund Existence | 14 years | 9 years | - |
Gain YTD | -2.342 | -4.077 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.64B | 11.7B | 57% |
Annual Yield % from dividends | 0.02 | 0.18 | 10% |
Returns for 1 year | -9.41 | -14.55 | 65% |
Returns for 3 years | -16.04 | -19.49 | 82% |
Returns for 5 years | -7.16 | -4.53 | 158% |
Returns for 10 years | 8.59 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
YCL | 24.40 | 0.40 | +1.67% |
ProShares Ultra Yen | |||
BMEZ | 13.99 | 0.04 | +0.29% |
BlackRock Health Sciences Term Trust | |||
PDN | 33.52 | 0.01 | +0.03% |
Invesco RAFI Developed Mkts ex-US S-METF | |||
SIXJ | 28.97 | -0.36 | -1.22% |
AllianzIM US Lrg Cp 6M Bfr10 Jan/Jul ETF | |||
DYLG | 24.54 | -0.49 | -1.96% |
Global X Dow 30 Covered Call & GrowthETF |